Tumour immunology: alternative perspectives.
Seljelid
R
R
Department of Experimental Pathology, Institute of Medical Biology, University of Tromsø, Norway.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D002648:Child; D003238:Connective Tissue / Q000502:physiology; D006801:Humans; D007111:Immunity, Cellular; D007157:Immunologic Surveillance; D007167:Immunotherapy; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008264:Macrophages / Q000502:physiology*; D008648:Mesoderm / Q000502:physiology; D051379:Mice; D018448:Models, Immunological; D009369:Neoplasms / Q000737:chemistry / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D012075:Remission, Spontaneous; D014714:Vertebrates / Q000276:immunology
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm